Zobrazeno 1 - 10
of 28
pro vyhledávání: '"D. Beirne"'
Autor:
Susan C Short, Elizabeth S. Appleton, Gemma Migneco, David Taggart, Simon Thomson, Gerard J. Nuovo, Lucy F. Stead, Sergio A. Quezada, Samantha J. Turnbull, Adel Samson, Philip van Hille, Richard G. Vile, Julia V. Cockle, D. Beirne, Fiona Collinson, Fiona Errington-Mais, Karen Scott, Peter Selby, Euan S. Polson, Kevin J. Harrington, Erica B. Wilson, Heiko Wurdak, Martin Fuller, Stephen Griffin, Jill Thompson, Timothy Kottke, Hardev Pandha, Gnanamurthy Sivakumar, Chris Twelves, Ailsa Rose, Christy Ralph, Andrew Furness, Elizabeth Ilett, Robert Corns, Emma West, D. Alan Anthoney, Matthew C. Coffey, Ryan K. Mathew, Alan Melcher
Immune checkpoint inhibitors, including those targeting programmed cell death protein 1 (PD-1), are reshaping cancer therapeutic strategies. Evidence suggests, however, that tumor response and patient survival are determined by tumor programmed death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4899fce1ad145ea879d424f0b5ba845
Autor:
Martin Gore, Poulam M. Patel, D. Beirne, Karen Thomas, James Larkin, S Bate, Tim Eisen, I Gibbens, S A Hughes
Publikováno v:
British Journal of Cancer
Temozolomide is an alkylating agent with activity in the treatment of melanoma metastatic to the brain. Lomustine is a nitrosurea that crosses the blood brain barrier and there is evidence to suggest that temozolomide may reverse resistance to lomust
Autor:
Alison Merrick, Oliver Donnelly, Amer Aldouri, Hardev Pandha, Karen Scott, David Alan Anthoney, Emma West, Victoria A. Jennings, Peter Selby, Victoria Roulstone, Ruth Morgan, Matthew C. Coffey, Kevin J. Harrington, D. Beirne, Joan N. Kyula, Giles J. Toogood, Robin Prestwich, R. Adair, Gerard J. Nuovo, Martin Fuller, R. Dave, Richard G. Vile, S. Fraser, Alan Melcher, Ailsa Rose
Publikováno v:
Science translational medicine. 4(138)
Oncolytic viruses, which preferentially lyse cancer cells and stimulate an antitumor immune response, represent a promising approach to the treatment of cancer. However, how they evade the antiviral immune response and their selective delivery to, an
Autor:
Poulam M. Patel, Barry W. Hancock, Paul Vasey, Angus G. Dalgleish, Sheryl Sim, J.M. Tourani, Colin Johnston, D. Beirne, Anthea J. Stanley, David Khayat, Peter Selby, Rosamonde E. Banks, D.O. O’Donnell, Andrew Protheroe
Publikováno v:
European journal of cancer (Oxford, England : 1990). 44(2)
Two studies were carried out to evaluate heat-killed Mycobacterium vaccae SRL172 as an immunotherapeutic agent for patients with metastatic, post-nephrectomy, renal cell carcinoma. In the first study, 60 patients in France and the UK received injecti
Autor:
D. T. Adroja, J. P. Allen, Jens Jensen, K. Habicht, Robert Bewley, E. D. Beirne, D. Fort, K.A. McEwen
Publikováno v:
Physical Review B. 73
Inelastic neutron-scattering experiments have been carried out on a polycrystalline sample of PrNiSn, and seven of the eight excited crystal-field singlets of the Pr ions were detected. The system stays paramagnetic, at least down to $0.9\phantom{\ru
Publikováno v:
The Journal of nervous and mental disease. 190(8)
It is proposed that poor insight in schizophrenia may be explained by neuropsychological dysfunction and linked to the negative syndrome, which in turn may be related to structural neurological impairment. This study tested the hypothesis that poor i
Autor:
Michael L. Waller, P. Selby, E. West, A. Anthony, A. Melcher, P.J. Robinson, A. Lubenko, D. Beirne
Publikováno v:
Nuclear Medicine Communications. 28:A17-A18
Publikováno v:
Applied Physics A: Materials Science & Processing. 74:s910-s911
Inelastic neutron scattering results from a single crystal of the rare earth intermetallic PrNiSn are presented. Crystalline electric field excitations are found at 0.5, 2.4 and around 3.5 meV. The lower modes show little dispersion over q, but the 3
Publikováno v:
European Journal of Cancer. 47:S658
Autor:
H D, Beirne
Publikováno v:
Arctic medical research.